What Should You Consider When Writing for a Dental Publication?

Compend Contin Educ Dent

Clinic Director, Cavity Busters Doylestown, Doylestown, Pennsylvania; Adjunct Professor, Pediatric Dentistry, University of Texas Health Science Center at San Antonio (Dental School); Clinical Professor, Pediatric Dentistry, Case Western Reserve University School of Dental Medicine, Cleveland, Ohio.

Published: September 2021

Good writing in dentistry involves both a depth of technical knowledge and experience and a command of more "classical" disciplines of knowledge and education, such as language, grammar, rhetoric, and logic. All of these factors influence the psychology and rhetorical interpretive mechanisms by which readers process and derive meaning from written text and are especially relevant to effective technical and medical writing.

Download full-text PDF

Source

Publication Analysis

Top Keywords

consider writing
4
writing dental
4
dental publication?
4
publication? good
4
good writing
4
writing dentistry
4
dentistry involves
4
involves depth
4
depth technical
4
technical knowledge
4

Similar Publications

Aims: Frozen shoulder is a common and debilitating condition characterized by pain and restricted movement at the glenohumeral joint. Various treatment methods have been explored to alleviate symptoms, with suprascapular nerve block (SSNB) emerging as a promising intervention. This meta-analysis aimed to assess the effectiveness of SSNB in treating frozen shoulder.

View Article and Find Full Text PDF

Numerical investigation of performance and exergy analysis in parabolic trough solar collectors.

Sci Rep

December 2024

Department of Mechanical and Aerospace Engineering, School of Engineering, University of Petroleum & Energy Studies (UPES), Dehradun, Uttarakhand, 248007, India.

This numerical investigation examines the performance and exergy analysis of parabolic trough solar collectors, focusing on the substitution of the conventional circular absorber with a rhombus-shaped absorber. By evaluating the thermal and fluid dynamics properties, this study aims to identify improvements in overall system performance and efficiency. This numerical study conducts a comprehensive thermal analysis of parabolic trough solar collectors by comparing a rhombus-shaped absorber with a conventional circular absorber.

View Article and Find Full Text PDF

Background: Dual inhibition of cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and programmed death ligand 1 (PD-L1) has been shown to be an effective treatment strategy in many cancers. We sought to determine the objective response rate of combination durvalumab (D) plus tremelimumab (TM) in parallel cohorts of patients with carefully selected rare cancer types in which these agents had not previously been evaluated in phase II trials and for which there was clinical or biological rationale for dual immune checkpoint inhibitor therapy to be active.

Methods: We designed a multi-centre, non-blinded, open-label phase II basket trial with each of the following 8 rare cancers considered a separate phase II trial: salivary carcinoma, carcinoma of unknown primary (CUP) with tumour infiltrating lymphocytes and/or expressing PD-L1, mucosal melanoma, acral melanoma, osteosarcoma, undifferentiated pleomorphic sarcoma, clear cell carcinoma of the ovary (CCCO) or squamous cell carcinoma of the anal canal (SCCA).

View Article and Find Full Text PDF

What are clinically significant anti-drug antibodies and why is it important to identify them.

Front Immunol

December 2024

translational Pharmacokinetics Pharmacodynamics (tPKPD), Genentech Inc., San Francisco, CA, United States.

The FDA has released new draft guidance to standardize how immunogenicity of protein therapeutics is described in product labels. A key aspect to this new guidance is that companies should describe anti-drug antibodies that have clinical significance in addition to reporting ADAs' incidence. Factors to consider when determining clinical significance include if those antibodies have a significant effect on the drug's pharmacokinetics, pharmacodynamics, efficacy, and/or safety.

View Article and Find Full Text PDF

Background: Intravitreal anti-vascular endothelial growth factor (VEGF) treatment for diabetic macular oedema (DME) may begin with several initial monthly doses. Characteristics, treatment patterns and outcomes were compared for eyes with DME that did and did not receive such initial doses.

Methods: This was a retrospective database study using American Academy of Ophthalmology Intelligent Research in Sight Registry data (01/01/15-31/12/20; index period).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!